Metabolic reserve as a determinant of cognitive aging

Journal of Alzheimer's Disease

Volumn 30, Issue SUPPL.2, 2012, Pages

  Stranahan, Alexis M ^a   Mattson, Mark P ^b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Brain derived neurotrophic factor (BDNF); caloric restriction; diabetes; diet; exercise; insulin; metabolic syndrome; neurodegeneration

Indexed keywords

AMYLOID BETA PROTEIN; BIOLOGICAL MARKER; BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; FIBROBLAST GROWTH FACTOR 2; GLUCOSE; GLUCOSE TRANSPORTER; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 3; GLYCOGEN SYNTHASE KINASE 3BETA; INSULIN; LEPTIN; MESSENGER RNA; NEUROTROPHIC FACTOR; NEUROTROPHIN; NEUROTROPHIN RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN TYROSINE KINASE A; SOMATOMEDIN C; TAU PROTEIN;

AGING; ALZHEIMER DISEASE; BIOACCUMULATION; BRAIN REGION; CALORIC INTAKE; CELL METABOLISM; COGNITIVE DEFECT; ENERGY METABOLISM; EXERCISE; GLUCOSE METABOLISM; HIPPOCAMPUS; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIFESTYLE; METABOLIC CAPACITY; MILD COGNITIVE IMPAIRMENT; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; PROTEIN PHOSPHORYLATION; REVIEW; SEDENTARY LIFESTYLE; SENILE PLAQUE; SIGNAL TRANSDUCTION;

EID: 84862656430     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2011-110899     Document Type: Review

References (92)

1. Albert MS, Blacker D (2008) Mild cognitive impairment and dementia. Annu Rev Clin Psychol 2, 379-388. (Pubitemid 43799810)
2. Evans DA, Beckett LA, Field TS, Feng L, Albert MS, Bennett DA, Tycko B, Mayeux R (1997) Apolipoprotein E epsilon4 and incidence of Alzheimer disease in a community population of older persons. JAMA 277, 822-824. (Pubitemid 27111319)
3. Hillman CH, Erickson KI, Kramer AF (2008) Be smart, exercise your heart: Exercise effects on brain and cognition. Nat Rev Neurosci 9, 58-65. (Pubitemid 350295689)
4. Luchsinger JA, Tang MX, Shea S, Mayeux R (2002) Caloric intake and the risk of Alzheimer disease. Arch Neurol 59, 1258-1263. (Pubitemid 34856378)
5. Scarmeas N, Luchsinger JA, Schupf N, Brickman AM, Cosentino S, Tang MX, Stern Y (2009) Physical activity, diet, and risk of Alzheimer disease. JAMA 302, 627-637.
6. Stern Y (2009) Cognitive reserve. Neuropsychologia 47, 2015-2028.
7. Kapogiannis D, Mattson MP (2011) Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's disease. Lancet Neurol 10, 187-198.
8. Craft S (2009) The role of metabolic disorders in Alzheimer disease and vascular dementia: Two roads converged. Arch Neurol 66, 300-305.
9. Llorens-Martín M, Torres-Alemán I, Trejo JL (2009) Mechanisms mediating brain plasticity: IGF1 and adult hippocampal neurogenesis. Neuroscientist 15, 134-148.
10. Nagahara AH, Tuszynski MH (2011) Potential therapeutic uses of BDNF in neurological and psychiatric disorders. Nat Rev Drug Discov 10, 209-219.
11. Suji G, Sivakami S (2004) Glucose, glycation and aging. Biogerontology 5, 365-373. (Pubitemid 40057979)
12. Harvey J (2007) Leptin regulation of neuronal excitability and cognitive function. Curr Opin Pharmacol 7, 643-647. (Pubitemid 350177556)
13. Scarmeas N, Stern Y, Mayeux R, Manly JJ, Schupf N, Luchsinger JA (2009) Mediterranean diet and mild cognitive impairment. Arch Neurol 66, 216-225.
14. Whitmer RA, Gustafson DR, Barrett-Connor E, Haan MN, Gunderson EP, Yaffe K (2008) Central obesity and increased risk of dementia more than three decades later. Neurology 71, 1057-1064.
15. Rolandsson O, Backeström A, Eriksson S, Hallmans G, Nils-son LG (2008) Increased glucose levels are associated with episodic memory in nondiabetic women. Diabetes 57, 440-443.
16. Velayudhan L, Poppe M, Archer N, Proitsi P, Brown RG, Lovestone S (2010) Risk of developing dementia in people with diabetes and mild cognitive impairment. Br J Psychiatry 196, 36-40.
17. Reaven GM, Thompson LW, Nahum D, Haskins E (1990) Relationship between hyperglycemia and cognitive function in older NIDDM patients. Diabetes Care 13, 16-21. (Pubitemid 20024725)
18. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR (1997) Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 277, 813-817. (Pubitemid 27111317)
19. Lye TC, Shores EA (2000) Traumatic brain injury as a risk factor for Alzheimer's disease: A review. Neuropsychol Rev 10, 115-129. (Pubitemid 30480342)
20. Uryu K, Laurer H, McIntosh T, Praticò D, Martinez D, Leight S, Lee VM, Trojanowski JQ (2002) Repetitive mild brain trauma accelerates Abeta deposition, lipid peroxidation, and cognitive impairment in a transgenic mouse model of Alzheimer amyloidosis. J Neurosci 22, 446-454. (Pubitemid 34049082)
21. Yaffe K, Fiocco AJ, Lindquist K, Vittinghoff E, Simonsick EM, Newman AB, Satterfield S, Rosano C, Rubin SM, Ayon-ayon HN, Harris TB (2009) Health ABC Study, Predictors of maintaining cognitive function in older adults: The Health ABC study. Neurology 72, 2029-2035.
22. Engelhart MJ, Geerlings MI, Ruitenberg A, van Swieten JC, Hofman A, Witteman JC, Breteler MM (2002) Dietary intake of antioxidants and risk of Alzheimer disease. JAMA 287, 3223-3229. (Pubitemid 34686103)
23. Xu W, Caracciolo B, Wang HX, Winblad B, Bäckman L, Qiu C, Fratiglioni L (2010) Accelerated progression from mild cognitive impairment to dementia in people with diabetes. Diabetes 59, 2928-2935.
24. Muzumdar R, Allison DB, Huffman DM, Ma X, Atzmon G, Einstein FH, Fishman S, Poduval AD, McVei T, Keith SW, Barzilai N (2008) Visceral adipose tissue modulates mammalian longevity. Aging Cell 7, 438-440. (Pubitemid 351663912)
25. Levin BE (2005) Factors promoting and ameliorating the development of obesity. Physiol Behav 86, 633-639. (Pubitemid 41728981)
26. Erickson KI, Voss MW, Prakash RS, Basak C, Szabo A, Chaddock L, Kim JS, Heo S, Alves H, White SM, Wojcicki TR, Mailey E, Vieira VJ, Martin SA, Pence BD, Woods JA, McAuley E, Kramer AF (2011) Exercise training increases size of hippocampus and improves memory. Proc Natl Acad Sci U S A 108, 3017-3022.
27. Erickson KI, Prakash RS, Voss MW, Chaddock L, Hu L, Morris KS, White SM, Wójcicki TR, McAuley E, Kramer AF (2009) Aerobicfitnessisassociated with hippocampal volume in elderly humans. Hippocampus 19, 1030-1039.
28. Scarmeas N, Luchsinger JA, Stern Y, Gu Y, He J, Decarli C, Brown T, Brickman AM (2011) Mediterranean diet and magnetic resonance imaging-assessed cerebrovascular disease. Ann Neurol 69, 257-268.
29. Bruehl H, Wolf OT, Sweat V, Tirsi A, Richardson S, Convit A (2009) Modifiers of cognitive function and brain structure in middle-aged and elderly individuals with type 2 diabetes mellitus. Brain Res 1280, 186-194.
30. Reijmer YD, van den Berg E, de Bresser J, Kessels RP, Kappelle LJ, Algra A, Biessels GJ, (2011) Utrecht Diabetic Encephalopathy Study Group, Accelerated cognitive decline in patients with type 2 diabetes: MRI correlates and risk factors. Diabetes Metab Res Rev 27, 195-202.
31. Raji CA, Ho AJ, Parikshak NN, Becker JT, Lopez OL, Kuller LH, Hua X, Leow AD, Toga AW, Thompson PM (2010) Brain structure and obesity. Hum Brain Mapp 31, 353-364.
32. Haley AP, Gonzales MM, Tarumi T, Miles SC, Goudarzi K, Tanaka H (2010) Elevated cerebral glutamate and myo-inositol levels in cognitively normal middle-aged adults with metabolic syndrome. Metab Brain Dis 25, 397-405.
33. Gerritsen L, Comijs HC, van der Graaf Y, Knoops AJ, Pen-ninx BW, Geerlings MI (2011) Depression, Hypothalamic Pituitary Adrenal Axis, and Hippocampal and Entorhinal Cortex Volumes-The SMART Medea Study. Biol Psychiatry 70, 373-380.
34. Frisardi V, Panza F, Farooqui AA (2011) Late-life depression and Alzheimer's disease: The glutamatergic system inside of this mirror relationship. Brain Res Rev 67, 344-355.
35. Arroyo C, Hu FB, Ryan LM, Kawachi I, Colditz GA, Speizer FE, Manson J (2004) Depressive symptoms and risk of type 2 diabetes in women. Diabetes Care 27, 129-133. (Pubitemid 38196721)
36. Frisardi V, Solfrizzi V, Capurso C, Imbimbo BP, Vendemiale G, Seripa D, Pilotto A, Panza F (2010) Isinsulin resistant brain state a central feature of the metabolic-cognitive syndrome? J Alzheimers Dis 21, 57-63.
37. Reger MA, Watson GS, Green PS, Baker LD, Cholerton B, Fishel MA, Plymate SR, Cherrier MM, Schellenberg GD, Frey WH 2nd, Craft S (2008) Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adults. J Alzheimers Dis 13, 323-31. (Pubitemid 352039034)
38. Schuur M, Henneman P, van Swieten JC, Zillikens MC, de Koning I, Janssens AC, Witteman JC, Aulchenko YS, Frants RR, Oostra BA, van Dijk KW, van Duijn CM (2010) Insulinresistance and metabolic syndrome are related to executive function in women in a large family-based study. Eur J Epidemiol 25, 561-568.
39. Messier C, Teutenberg K (2005) The role of insulin, insulin growth factor, and insulin-degrading enzyme in brain aging and Alzheimer's disease. Neural Plasticity 12, 311-328. (Pubitemid 43072007)
40. Kim B, Backus C, Oh S, Hayes JM, Feldman EL (2009) Increased tau phosphorylation and cleavage in mouse models of type 1 and type 2 diabetes. Endocrinology 150, 5294-5301.
41. Valente T, Gella A, Fernàndez-Busquets X, Unzeta M, Durany N (2010) Immunohistochemical analysis of human brain suggests pathological synergism of Alzheimer's disease and diabetes mellitus. Neurobiol Dis 37, 67-76.
42. Stranahan AM, Lee K, Becker KG, Zhang Y, Maudsley S, Martin B, Cutler RG, Mattson MP (2010) Hippocampal gene expression patterns underlying the enhancement of memory by running in aged mice. Neurobiol Aging 31, 1937-1949.
43. Adlard PA, Perreau VM, Pop V, Cotman CW (2005) Voluntary exercise decreases amyloid load in a transgenic model of Alzheimer's disease. J Neurosci 25, 4217-4221. (Pubitemid 40628765)
44. Halagappa VK, Guo Z, Pearson M, Matsuoka Y, Cutler RG, Laferla FM, Mattson MP (2007) Intermittent fasting and caloric restriction ameliorate age-related behavioral deficits in the triple-transgenic mouse model of Alzheimer's disease. Neurobiol Dis 26, 212-220. (Pubitemid 46436499)
45. Stranahan AM, Lee K, Martin B, Maudsley S, Golden E, Cutler RG, Mattson MP (2009) Voluntary exercise and caloric restriction enhance hippocampal dendritic spine density and BDNF levels in diabetic mice. Hippocampus 19, 951-961.
46. Rinne JO, Någren K (2010) Positron emission tomography in at risk patients and in the progression of mild cognitive impairment to Alzheimer's disease. J Alzheimers Dis 19, 291-300.
47. Mooradian AD, Chung HC, ShahGN (1997) GLUT-1 expression in the cerebra of patients with Alzheimer's disease. Neurobiol Aging 18, 469-474. (Pubitemid 27497142)
48. Liu Y, Liu F, Iqbal K, Grundke-Iqbal I, Gong CX (2008) Decreased glucose transporters correlate to abnormal hyper-phosphorylation of tau in Alzheimer disease. FEBS Lett 582, 359-364.
49. Hooijmans CR, Graven C, Dederen PJ, Tanila H, van Groen T, Kiliaan AJ (2007) Amyloid beta deposition is related to decreased glucose transporter-1 levels and hippocampal atrophy in brains of aged APP/PS1 mice. Brain Res 1181, 93-103. (Pubitemid 350050914)
50. Robertson LA, Moya KL, Breen KC (2004) The potential role of tau protein O-glycosylation in Alzheimer's disease. J Alzheimers Dis 6, 489-495. (Pubitemid 40921720)
51. Li X, Lu F, Wang JZ, Gong CX (2006) Concurrent alterations of O-GlcNAcylation and phosphorylation of tau in mouse brains during fasting. Eur J Neurosci 23, 2078-2086.
52. Xu X, Zhan M, Duan W, Prabhu V, Brenneman R, Wood W, Firman J, Li H, Zhang P, Ibe C, Zonderman AB, Longo DL, Poosala S, Becker KG, Mattson MP (2007) Gene expression atlas of the mouse central nervous system: Impact and interactions of age, energy intake and gender. Genome Biol 8, R234-.
53. Hâkansson ML, Brown H, Ghilardi N, Skoda RC, Meister B (1998) Leptin receptor immunoreactivity in chemically defined target neurons of the hypothalamus. J Neurosci 18, 559-572. (Pubitemid 28046812)
54. Morton GJ, Schwartz MW (2011) Leptin and the central nervous system control of glucose metabolism. Physiol Rev 91, 389-411.
55. Caron E, Sachot C, Prevot V, Bouret SG (2010) Distribution of leptin-sensitive cells in the postnatal and adult mouse brain. J Comp Neurol 518, 459-476.
56. Knight ZA, Hannan KS, Greenberg ML, Friedman JM (2010) Hyperleptinemia is required for the development of leptin resistance. PLoS One 5, e11376.
57. Lieb W, Beiser AS, Vasan RS, Tan ZS, Au R, Harris TB, Roubenoff R, Auerbach S, DeCarli C, Wolf PA, Seshadri S (2009) Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging. JAMA 302, 2565-2572.
58. Greco SJ, Sarkar S, Casadesus G, Zhu X, Smith MA, Ashford JW, Johnston JM, Tezapsidis N (2009) Leptin inhibits glyco-gen synthase kinase-3beta to prevent tau phosphorylation in neuronal cells. Neurosci Lett 455, 191-194.
59. Greco SJ, Bryan KJ, Sarkar S, Zhu X, Smith MA, Ashford JW, Johnston JM, Tezapsidis N, Casadesus G (2010) Lep-tin reduces pathology and improves memory in a transgenic mouse model of Alzheimer's disease. J Alzheimers Dis 19, 1155-1167.
60. Grillo CA, Piroli GG, Evans AN, Macht VA, Wilson SP, Scott KA, Sakai RR, Mott DD, Reagan LP (2011) Obesity/hyperleptinemic phenotype adversely affects hip-pocampal plasticity: Effects of dietary restriction. Physiol Behav 104, 235-241.
61. Dyck DJ (2005) Leptin sensitivity in skeletal muscle is modulated by diet and exercise. Exerc Sport Sci Rev 33, 189-194. (Pubitemid 41513203)
62. MattsonMP, Murrain M, GuthriePB, KaterSB (1989) Fibrob-last growth factor and glutamate: Opposing roles in the generation and degeneration of hippocampal neuroarchitecture. J Neurosci 9, 3728-3740. (Pubitemid 20004868)
63. Zhang Y, Tatsuno T, Carney JM, Mattson MP (1993) Basic FGF, NGF, and IGFs protect hippocampal and cortical neurons against iron-induced degeneration. J Cereb Blood Flow Metab 13, 378-388. (Pubitemid 23129390)
64. Kawamata T, Dietrich WD, Schallert T, Gotts JE, Cocke RR, Benowitz LI, Finklestein SP (1997) Intracisternal basic fibroblast growth factor enhances functional recovery and up-regulates the expression of a molecular marker of neuronal sprouting following focal cerebral infarction. Proc Natl Acad Sci U S A 94, 8179-8184. (Pubitemid 27343797)
65. +-ATPase activity in hippocampal neurons. Brain Res 756, 205-214. (Pubitemid 27241628)
66. Cheng B, Mattson MP (1992) IGF-I and IGF-II protect cultured hippocampal and septal neurons against calcium-mediated hypoglycemic damage. J Neurosci 12, 1558-1566.
67. Doré S, Kar S, Quirion R (1997) Insulin-like growth factor I protects and rescues hippocampal neurons against beta-amyloid- and human amylin-induced toxicity. Proc Natl Acad Sci U S A 94, 4772-4777. (Pubitemid 27194319)
68. Cohen E, Paulsson JF, Blinder P, Burstyn-Cohen T, Du D, Estepa G, Adame A, Pham HM, Holzenberger M, Kelly JW, Masliah E, Dillin A (2009) Reduced IGF-1 signaling delays age-associated proteotoxicity in mice. Cell 139, 1157-1169.
69. Cheng B, Mattson MP (1994) NT-3 and BDNF protect CNS neurons against metabolic/excitotoxic insults. Brain Res 640, 56-67. (Pubitemid 24086531)
70. Blurton-Jones M, Kitazawa M, Martinez-Coria H, Castello NA, Müller FJ, Loring JF, Yamasaki TR, Poon WW, Green KN, LaFerla FM (2009) Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease. Proc Natl Acad Sci U S A 106, 13594-13599.
71. Caccamo A, Maldonado MA, Bokov AF, Majumder S, Oddo S (2010) CBP gene transfer increases BDNF levels and ameliorates learning and memory deficits in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A 107, 22687-22692.
72. Williams BJ, Eriksdotter-Jonhagen M, Granholm AC (2006) Nerve growth factor in treatment and pathogenesis of Alzheimer's disease. Prog Neurobiol 80, 114-128. (Pubitemid 44739167)
73. Waterhouse EG, Xu B (2009) New insights into the role of brain-derived neurotrophic factor in synaptic plasticity. Mol Cell Neurosci 42, 81-89.
74. Cheng A, Wang S, Cai J, Rao MS, Mattson MP (2003) Nitric oxide acts in a positive feedback loop with BDNF to regulate neural progenitor cell proliferation and differentiation in the mammalian brain. Dev Biol 258, 319-333. (Pubitemid 36683134)
75. Neeper SA, Gómez-Pinilla F, Choi J, Cotman CW (1996) Physical activity increases mRNA for brain-derived neu-rotrophic factor and nerve growth factor in rat brain. Brain Res 726, 49-56. (Pubitemid 26292229)
76. Arumugam TV, Phillips TM, Cheng A, Morrell CH, Mattson MP, Wan R (2010) Age and energy intake interact to modify cell stress pathways and stroke outcome. Ann Neurol 67, 41-52.
77. Stranahan AM, Norman ED, Lee K, Cutler RG, Telljohann RS, Egan JM, Mattson MP (2008) Diet-induced insulin resistance impairs hippocampal synaptic plasticity and cognition in middle-aged rats. Hippocampus 18, 1085-1088.
78. Reichardt LF (2006) Neurotrophin-regulated signalling pathways. Philos Trans R Soc Lond B Biol Sci 361, 1545-1564. (Pubitemid 44450210)
79. Kernie SG, Liebl DJ, ParadaLF (2000) BDNF regulates eating behavior and locomotor activity in mice. EMBO J 19, 1290-1300. (Pubitemid 30151025)
80. Xu B, Goulding EH, Zang K, Cepoi D, Cone RD, Jones KR, Tecott LH, Reichardt LF (2003) Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor. Nat Neurosci 6, 736-742. (Pubitemid 36792889)
81. Nonomura T, Tsuchida A, Ono-Kishino M, Nakagawa T, Taiji M, Noguchi H (2001) Brain-derived neurotrophic factor regulates energy expenditure through the central nervous system in obese diabetic mice. Int J Exp Diabetes Res 2, 201-209.
82. Tonra JR, Ono M, Liu X, Garcia K, Jackson C, Yancopoulos GD, Wiegand SJ, Wong V (1999) Brain-derived neurotrophic factor improves blood glucose control and alleviates fasting hyperglycemia in C57BLKS-Lepr (db) /lepr (db) mice. Diabetes 48, 588-594. (Pubitemid 29106874)
83. Duan W, Guo Z, Jiang H, Ware M, Mattson MP (2003) Reversal of behavioral and metabolic abnormalities, and insulin resistance syndrome, bydietary restrictioninmice deficient in brain-derived neurotrophic factor. Endocrinology 144, 2446-2453. (Pubitemid 36629896)
84. Burkhalter J, Fiumelli H, Allaman I, Chatton JY, Martin JL (2003) Brain-derived neurotrophic factor stimulates energy metabolism in developing cortical neurons. J Neurosci 23, 8212-8220. (Pubitemid 37129637)
85. Phillips HS, Hains JM, Armanini M, Laramee GR, Johnson SA, Winslow JW (1991) BDNF mRNA is decreased in the hippocampusofindividuals with Alzheimer's disease.Neuron 7, 695-702.
86. Connor B, Young D, Yan Q, Faull RL, Synek B, Dragunow M (1997) Brain-derived neurotrophic factor is reduced in Alzheimer's disease. Mol Brain Res 49, 71-81. (Pubitemid 27453116)
87. Tong L, Thornton PL, Balazs R, Cotman CW (2001) Beta-amyloid- (1-42) impairs activity-dependent cAMP-response element-binding protein signaling in neurons at concentrations in which cell survival Is not compromised. J Biol Chem 276, 17301-17306.
88. Mufson EJ, Lavine N, Jaffar S, Kordower JH, Quirion R, SaragoviHU (1997) Reductioninp140-TrkA receptor protein within the nucleus basalis and cortex in Alzheimer's disease. Exp Neurol 146, 91-103. (Pubitemid 27319723)
89. Culmsee C, Stumm RK, Schäfer MK, Weihe E, Krieglstein J (1999) Clenbuterol induces growth factor mRNA, activates astrocytes, and protects rat brain tissue against ischemic damage. Eur J Pharmacol 379, 33-45. (Pubitemid 29492944)
90. Jang SW, Liu X, Chan CB, Weinshenker D, Hall RA, Xiao G, Ye K (2009) Amitriptyline is a TrkA and TrkB receptor agonist that promotes TrkA/TrkB heterodimerization and has potent neurotrophic activity. Chem Biol 16, 644-656.
91. Jang SW, Liu X, Yepes M, Shepherd KR, Miller GW, Liu Y, Wilson WD, Xiao G, Blanchi B, Sun YE, Ye K (2010) A selective TrkB agonist with potent neurotrophic activities by 7, 8-dihydroxyflavone. Proc Natl Acad Sci U S A 107, 2687-2692.
92. Massa SM, Yang T, Xie Y, Shi J, Bilgen M, Joyce JN, Nehama D, Rajadas J, Longo FM (2010) Small molecule BDNF mimetics activate TrkB signaling and prevent neuronal degeneration in rodents. J Clin Invest 120, 1774-1785.